Thyroid clinical trials at University of California Health

1 research study open to eligible people

Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
open to eligible people ages 18-100
The purpose of this study is to compare the performance of Afirma GSC and ThyroSeq v.3 in indeterminate thyroid nodules to determine which test can allow more patients to avoid unnecessary surgery and preserve quality of life. In the initial phase of this study, the performance of Afirma GEC and ThyroSeq v.2 were compared.
at UCLA

Last updated: May 2022

Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules